Headlines can present inaccurate pictures of a company's quarterly performance. For instance, a gander at the few words attempting to lure you into articles about Dow Chemical
Technically, I suppose, that contention is accurate, since the company's profit dipped to $597 million, or $0.45 a share, compared with $795 million, or $0.63 a share, a year earlier. But as you know, that's a careful comparison of apples to oranges. If you back out discontinued operations, along with other items, it earned $0.54 per share, a sizable $0.30 jump from the same quarter in 2009.
Furthermore, sales, excluding divestitures, jumped by 23% to $12.87 billion. On that basis, the analysts' consensus expectation that the company would earn $0.41 a share on revenues of $12.81 billion appeared straight from left field.
Dow's solid performance was hardly attributable to a single unit or two. Indeed, many of its segments checked in with double-digit sales increases, led by Basic Chemicals, with a 33% improvement.
Geographically, volume growth was highest in Europe, the Middle East, and Africa (EMEA), along with North America. Both areas grew by at least 15%.
Clearly, trends in the chemical industry can tell us a great deal about the direction of our overall economy. On that basis, increased guidance from DuPont
Dow CEO Andrew Liveris perhaps summed up both his company's -- and the broader global industry's -- prospects: "Our view is that robust growth in emerging economies will continue as domestic demand in fast-growing geographies such as Brazil, Asia, Middle East, and Eastern Europe is further strengthening in a number of leading end-markets."
He added that "we are also encouraged to see signs of improved growth in North America and Europe, especially Germany, which point toward increased momentum in the developed nations."
So Dow has performed admirably, both operationally and financially -- its net debt to total capitalization was pared by 200 basis points in the quarter -- since its 2009 acquisition of specialty-chemicals maker Rohm & Haas. That strengthening appears to render it an especially compelling investment target for my Foolish friends.
Are you in the market for some sensible stock ideas? Try any of our Foolish newsletter services free for 30 days.
Want to read more about Dow? Add it to My Watchlist, which will find all of our Foolish analysis on this stock.
We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Fool contributor David Lee Smith doesn't own shares in any of the companies mentioned. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Large-Cap Stocks to Buy in February
These three companies have made investors millions. Here's why they'll keep doing so.
Will These Megamergers Gain Approval in 2017?
Low commodity prices have led to a wave of consolidation in agricultural industries. This year could make or break $186 billion in deals.
Did Warren Buffett Manipulate the Market in Dow Chemical Stock?
Some call it manipulation. This Fool calls it smart investing.